Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCOR
āļāļ·āđāļāļāļĢāļīāļĐāļąāļCencora Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 28, 1996
āļāļĩāļāļĩāđāļDr. Robert P. (Bob) Mauch, Ph.D.
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ42000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 28
āļāļĩāđāļāļĒāļđāđ1 West First Avenue
āđāļĄāļ·āļāļCONSHOHOCKEN
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNYSE Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ19428
āđāļāļĢāļĻāļąāļāļāđ16107277000
āđāļ§āđāļāđāļāļāđhttps://www.cencora.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCOR
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 28, 1996
āļāļĩāļāļĩāđāļDr. Robert P. (Bob) Mauch, Ph.D.
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
Mr. Lon R. Greenberg
Independent Director
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
Mr. Dennis M. Nally
Independent Director
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
Mr. Werner Baumann
Independent Director
Dr. Lorence H. Kim, M.D.
Independent Director
Ms. Lori J. Ryerkerk
Independent Director
Ms. Lauren M. Tyler
Independent Director
Mr. Bennett S. Murphy
Senior Vice President, Investor Relations
Senior Vice President, Investor Relations
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
Mr. Lon R. Greenberg
Independent Director
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
Mr. Dennis M. Nally
Independent Director
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
Mr. Werner Baumann
Independent Director
VanEck Pharmaceutical ETF
AdvisorShares Focused Equity ETF
First Trust Consumer Staples Alphadex Fund
Invesco Dorsey Wright Healthcare Momentum ETF
Janus Henderson Mid Cap Growth Alpha ETF
First Trust Dorsey Wright Momentum & Low Vol ETF
American Century Mid Cap Growth Impact ETF
iShares US Consumer Staples ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
VanEck Pharmaceutical ETF
āļŠāļąāļāļŠāđāļ§āļ5.23%
AdvisorShares Focused Equity ETF
āļŠāļąāļāļŠāđāļ§āļ4.8%
First Trust Consumer Staples Alphadex Fund
āļŠāļąāļāļŠāđāļ§āļ4.03%
Invesco Dorsey Wright Healthcare Momentum ETF
āļŠāļąāļāļŠāđāļ§āļ3.74%
Janus Henderson Mid Cap Growth Alpha ETF
āļŠāļąāļāļŠāđāļ§āļ3.67%
VanEck Retail ETF
āļŠāļąāļāļŠāđāļ§āļ3.26%
First Trust Dorsey Wright Momentum & Low Vol ETF
āļŠāļąāļāļŠāđāļ§āļ2.6%
American Century Mid Cap Growth Impact ETF
āļŠāļąāļāļŠāđāļ§āļ2.55%
iShares US Consumer Staples ETF
āļŠāļąāļāļŠāđāļ§āļ2.41%
ProShares Pet Care ETF
āļŠāļąāļāļŠāđāļ§āļ2.2%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
1.92B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023
COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ